Introduction
Obstetrics and Gynecology, The University of Alabama at Birmingham, Alabama, USA Although we often utilize dynamic testing [e.g. acute ACTH-(1-24) stimulation, insulin tolerance test, long-acting gonado- 4 To whom correspondence should be addressed at: Department of trophin stimulation, etc.] in the study of women with the polyObstetrics and Gynecology, The University of Kentucky School of Medicine, 800 Rose Street, Rm C-359, Lexington, Kentucky cystic ovary syndrome (PCOS), the impact of the stress of the USA test on its results has largely been ignored. We have previously observed that adrenal androgen concentrations are higher if the In order to test the hypothesis that adrenocortical overbasal samples for an acute ACTH-(1-24) test are obtained within activity, possibly related to the stress of testing, may impact 15 min of the placement of an i.v. catheter, compared to obtaining on the measurement of circulating androgen concentrations the samples after a 45 min rest period (R.Azziz, unpublished during glucose-induced hyperinsulinaemia, we prospectdata). It is possible that the stress of the placement of the i.v. ively screened 10 patients with the polycystic ovary syndrome catheter may cause a transient increase in adrenocortical activity, (PCOS) and nine healthy control women with an oral glucose probably mediated through increased ACTH stimulation. tolerance test (OGTT), before and after the administration Following experimentally induced increases in insulin, of dexamethasone. Blood sampling was performed at 0, 30, various investigators have demonstrated, in both normal women 60, 90, and 120 min following the oral ingestion of 75 g and patients with PCOS, a decrease in the circulating concentraof glucose, before and after the administration of 1.0 mg tions of the adrenal androgens, dehydroepiandrosterone (DHEA) dexamethasone on the evening prior to testing. Total and and DHEA sulphate (DHEAS), and/or an increase in testosterone free testosterone, androstenedione, dehydroepiandrosterone and androstenedione (Nestler et al., 1987 (Nestler et al., , 1989 Smith et al., (DHEA) , DHEA sulphate (DHEAS), cortisol, glucose and 1987; Diamond et al., 1991) . Alternatively, we (Buyalos et al., insulin were assessed during the 2 h OGTT. Women with 1991) and others (Dunaif and Graf, 1989 ; Elkind-Hirsch et al., PCOS had increased basal concentrations of free testoster-1991) have not been able to demonstrate these findings. In order one, total testosterone, androstenedione, and insulin comto explain these discordant observations, we have postulated that pared to control women. In women with PCOS an acute the stress associated with testing may impact on the results of decline in circulating concentrations of DHEAS occurred these studies. For example, a transient stress-induced rise in during the OGTT. In PCOS women there were no changes adrenal androgen concentrations may mask their legitimate insuin other ovarian or adrenal androgens during OGTT before lin-related decrease. Alternatively, if this phenomenon is shortor following dexamethasone administration. In control lived, it may actually result in a factitious decrease, since the women DHEA concentrations declined during the OGTT.
stress-induced elevation in androgen concentrations will resolve Following overnight dexamethasone suppression in control during the time of testing. To test this hypothesis, we studied, in women, circulating concentrations of DHEAS and testostera prospective controlled fashion, the adrenal androgen response one also declined. It is concluded that: (i) in PCOS women to a 2 h oral glucose tolerance test (OGTT) before and after only the concentration of circulating DHEAS decreased durovernight dexamethasone suppression. Dexamethasone was ing glucose-induced hyperinsulinaemia and dexamethasone administered in an effort to minimize the ACTH-mediated rises administration did not further alter androgen responses to in adrenal androgens resulting from the stress of i.v. catheter an OGTT; (ii) it is possible that, in these hyperandrogenic placement. patients, the insulin-related suppression of adrenocortical testosterone and DHEA is negated by their much greater Materials and methods ovarian secretion of these androgens; (iii) in control women DHEA concentrations acutely declined during the OGTT
Subjects

and the administration of dexamethasone resulted in the
Ten patients with PCOS and nine healthy control women were studied.
acute decline of DHEA, DHEAS, and testosterone; (iv) it
All PCOS subjects reported the perimenarchal onset of oligoappears that the stress related to testing impacts on the menorrhoea and all exhibited at least facial hirsutism. None was virilized or had acanthosis nigricans. None of the PCOS patients had androgen response to OGTT, at least in healthy women.
Area under the curve (AUC) values were calculated using the trapez- Table I . Comparison of characteristics between controls (n ϭ 9) and women oidal rule for glucose and insulin responses during OGTT using time with polycystic ovary syndrome (PCOS) (n ϭ 10) (in minutes) and the concentrations of glucose (mg/dl) and insulin (µU/ ml) at each time interval. Two-tailed Student's t-test for paired and 0.03) and insulin (10 Ϯ 5 versus 14 Ϯ 4 µU/ml, P ϭ 0.05) at
The mean ages were similar between PCOS and control women time 0 in control women (Table II) . In PCOS women there was (Table I ). All subjects were ambulatory during the day and slept between a significant rise in glucose (93 Ϯ 10 versus 103 Ϯ 15 mg/dl, 2300 and 0600 h. No subject, PCOS or control, had received hormonal P ϭ 0.01) but not insulin (24 Ϯ 27 versus 26 Ϯ 19 µU/ml, P ϭ medication within 30 days prior to study. Some of these subjects were 0.69) at time 0 following dexamethasone administration.
reported in a previous study (Buyalos et al., 1991) .
Dexamethasone administration resulted in an increase in the tee and all patients gave informed written consent. All OGTT were (Table II) . Alternatively, after dexamethasone administration the performed in the UCLA Clinical Research Center beginning between insulin AUC increased significantly only for controls 0800 and 0900 h, after 3 days of ജ300 g carbohydrate diet and a 10-(6900 Ϯ 1140 versus 11 940 Ϯ 4020 µU·min/ml, P ϭ 0.03), 12 h overnight fast. All control subjects were studied during the midalthough there was a trend toward an increase among PCOS As expected, in both PCOS and control women the concentra- ( Table III) . Total testosterone decreased with dexamethasone suppression only in patients with PCOS. Following dexametha-
Endocrine assays
sone administration, the value of circulating cortisol at time 0
Serum androstenedione, total and free testosterone, DHEA, DHEAS, was at or below the assay detection limit (Ͻ1.2 µg/dl) in 18/19 cortisol, insulin and plasma glucose were measured as previously described (Buyalos et al., 1991 (Buyalos et al., , 1993 . In our laboratory, the intra-assay study subjects.
coefficients of variation for these assays range between 4 and 6%. All
Androgen response during OGTT
samples from an individual woman were analysed in a single assay.
In control women, from 0 to 120 min during the OGTT, only DHEA decreased (mean change of -24.4%, P Ͻ 0.04); all other
Statistical analysis
androgens remaining essentially unchanged. Following the overChanges in steroid values were computed as the difference from baseline night administration of dexamethasone in control patients, a (time 0) to 120 min using one-way analysis of variance (ANOVA) with pair-wise comparisons using the least significant difference method.
significant decrease in not only DHEA, but also in DHEAS and R.P.Buyalos et al. 
PCOS ϭ polycystic ovary syndrome. a For abbreviations and conversion factors see Table I . b Values in parentheses represent mean percentage change. NS ϭ non-significant.
total testosterone was observed (mean changes of -8.9, -20.8 tions, the short-term physiological increases in insulin concentrations during the OGTT were sufficient to suppress circulating and -20.6% respectively, P Ͻ 0.03-0.003).
total testosterone, DHEA and DHEAS in healthy control women. In women with PCOS a decrease in DHEAS was noted during
The decrease in circulating testosterone during the OGTT may the OGTT (mean change of -9.4%, P Ͻ 0.01). In PCOS patients, reflect the significant adrenocortical component of this androgen dexamethasone administration did not alter this result, and (~25%). Alternatively, under non-glucocorticoid suppressed DHEAS was the only androgen to decrease during the OGTT conditions, only the decrease in DHEA was observed. (mean change of -5.6%, P Ͻ 0.04). Following dexamethasone
The changes in basal circulating androgen and cortisol conadministration, in both PCOS patients and controls, the value of centrations in women with PCOS and controls following dexacirculating cortisol was at or below the assay detection limit at methasone administration were as expected. Interestingly, even the conclusion of the OGTT (time 120 min).
the small dose of dexamethasone used in this study (1.0 mg on the evening before ACTH testing) was sufficient significantly to Discussion increase basal and stimulated glucose concentrations in both Data regarding the impact of physiological increases in insulin control and PCOS patients. Basal insulin concentrations and concentrations on adrenal androgens have been conflicting AUC insulin increased significantly during OGTT only among (Nestler et al., 1987 (Nestler et al., , 1989 Smith et al., 1987; Dunaif and Graf, control women. The inability to achieve a statistically significant 1989; Buyalos et al., 1991 Buyalos et al., , 1993 Diamond et al., 1991; Elkind- increase in AUC insulin secretion in PCOS subjects following Hirsch et al., 1991; Hubert et al., 1991; Azziz et al., 1995;  dexamethasone administration (despite a significant rise in AUC Norman et al., 1995) . In order to explain some of these discrepanglucose concentrations) is probably a reflection of the already cies we postulated that ACTH-mediated adrenocortical overmarkedly increased secretion of insulin associated with this activity resulting from the stress of the test itself may either condition. Thus, dynamic tests or therapies that incorporate 'lowmask or exacerbate the changes in adrenal androgens. Using dose' pre-test glucocorticoid administration may significantly overnight dexamethasone to diminish ACTH secretion, our data increase the circulating glucose concentrations, possibly through suggest that the presence of stress may have masked androgen a change in insulin resistance, and consequently alter the androchanges in response to the OGTT, at least in control subjects.
genic milieu, particularly in normal women. Cortisol concentrations were significantly reduced during the In PCOS women, the pretest administration of dexamethasone did not alter the androgen response to hyperinsulinaemia induced OGTT, reflecting ACTH inactivity. However, under these condi-by the OGTT. DHEAS concentrations declined significantly and the administration of dexamethasone resulted in the acute decline of DHEA, DHEAS, and testosterone. In conclusion, it during OGTT with and without dexamethasone administration. In women with PCOS, no other ovarian or adrenal androgen is possible that the stress associated with testing, and particularly i.v. catheter placement, may mask the decrease in adrenal androchanged during OGTT. However, a reduction in adrenal cortical activity was obtained following dexamethasone administration, gen concentrations associated with short-term physiological increases in insulin. This effect is far more evident among healthy as demonstrated by the fall in baseline concentrations of testosterone, androstenedione, DHEA, DHEAS and cortisol in these control women than those with PCOS, probably due to the greater ovarian androgen contribution to circulating androgen women. In the present study, in contrast to our previous report (Buyalos et al., 1991) , we observed a decrease in circulating concentrations in these latter patients. Finally, since even a small dose of dexamethasone administered before the test may result DHEAS among PCOS women during the OGTT-induced increase in insulin concentrations, regardless of the administrain significant increases in glucose and insulin responses, a preferable method of reducing stress-related changes in adrenocortical tion of pre-test glucocorticoid. It is possible that any decreases in the adrenocortical secretion of testosterone and/or DHEA function may be to allow subjects to rest for 45-60 min after i.v. catheter placement prior to beginning blood sampling. associated with the rise in insulin may be negated by the much greater ovarian secretion of these androgens in the women with PCOS.
